Overview

Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a short course of increased corticosteroid dosing with tapered dosing decreases seizure frequency as compared to standard corticosteroid dosing in patients with neurocysticercosis (NCC).
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Albendazole
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Omeprazole